DEFINITIVE PROXY STATEMENT

Company

Oncotelic Therapeutics, Inc.

Filed

May 28, 1999

Period of Report

June 29, 1999

Accession Number

0000914121-99-000538

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →